AD-5467
AD-5467 is a potent and selective aldose reductase inhibitor. AD-5467 exhibits antidiabetic effect. AD-5467 can be used for the research of metabolic disease, such as diabetes[1].
Product Specifications
CAS Number
[112808-22-7]
UNSPSC
12352005
Target
Aldose Reductase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
O=C(CN1C2=CC=CC(C(C)C)=C2OC(C(C)C)C1=S)O
Molecular Formula
C16H21NO3S
Molecular Weight
307.41
References & Citations
[1]Tawada H, et al. Studies on antidiabetic agents. IX. A new aldose reductase inhibitor, AD-5467, and related 1,4-benzoxazine and 1,4-benzothiazine derivatives: synthesis and biological activity. Chem Pharm Bull (Tokyo) . 1990 May;38 (5) :1238-45.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15122298 1 Vial
Lentiviral human RSC1A1 shRNA (UAS) - Lentiviral human RSC1A1 shRNA (UAS) (100)
Ask
View Details 
A2295-02D1-FITC 200 µL
ACE2, NT (Angiotensin-converting Enzyme 2, ACE-related Carboxypeptidase, Angiotensin-converting Enzyme Homolog, ACEH, Metalloprotease MPROT15, Processed Angiotensin-converting Enzyme 2, UNQ868/PRO1885) (FITC) discontinued
Ask
View Details 
GTR15089630 1 Vial
Lentiviral human SEC22A shRNA (UAS) - Lentiviral human SEC22A shRNA (UAS, iRFP) (25)
Ask
View Details